Abstract
Purpose:
The purpose of this study was to evaluate a self-administered risk-assessment scoring system for identifying Omani adults with type 2 diabetes mellitus (T2DM).
Methods:
An exploratory cross-sectional design was used. Simple random sampling was used to select 93 adults in Muscat. Ethical approval was obtained from the College of Nursing Research and Ethics Committee. The Finnish Diabetes Risk Score (FINDRISC) was used to collect the data in 2009. Informed consent was obtained from the participants. Data were analysed with the Pearson chi-square test.
Results:
A total of 9.7% of the adults had very high FINDRISC and 17.2% had slightly elevated risk of developing T2DM within 10 years. The risk assessment (family history, waist circumference, body mass index, physical activity, dietary intake, hypertension and high blood glucose) of T2DM was significant and positively related to the prediction of T2DM among Omani adults.
Keywords: Diabetes mellitus, diabetes nurse educator, risk assessment, risk score, screening, prediction, prevention
Introduction
With the rapid transition in economic development, industrialization and globalization have lead to lifestyle changes and increase in life expectancy in most areas of the world. This increase in lifestyle and cultural changes, including unhealthy dietary habits and decrease in physical activity, has been accompanied by an increase in the prevalence of non-communicable (chronic) diseases, including diabetes mellitus (DM). DM is considered as one of the major health problems worldwide. The number of adults with DM is approximately 194–246 million in the world, and these numbers will rise to 333–380 million people by 2025.1 An examination of preventable lifestyle-related risk factors of T2DM identified overweight, abdominal obesity and sedentary lifestyle with high saturated fat, refined carbohydrate, total energy and low dietary fibre intake.2–6 In some countries of the Eastern Mediterranean and Middle East Region, the prevalence of DM is among the highest in the world (9.4 in 2007) like Kuwait (18.85%), Bahrain (18.33%), Qatar (17.56%), Lebanon (16.59%) and Egypt (15.26%), and some of them are among the top 10 countries in the world in terms of prevalence of DM.1,7 There is an increase in prevalence of DM in Oman from 11.6% in 2000 (6.5% of males and 5.1% of females) to 15% in 2005 to 16.1% in 2008.8–11
Oman, a newly industrialized country, has experienced rapid socio-economic development over the past three decades, resulting in an increase in the prevalence of non-communicable diseases.10,12 A total of 30% of the population is overweight, 20% are obese, 41% have high cholesterol and 21% have metabolic syndrome.13 Type 2 diabetes mellitus (T2DM) is one of the most prevalent conditions (11.6% in 2000), and has become a health challenge in Oman.13,14 This has triggered an increase in morbidity (DM, ischaemic heart disease, asthma, polyneuropathy, etc.).15 It is predicted that the older adult population (currently 3.5% of the population) is expected to increase by 6-fold by 2030, which will also be a major contributing factor for the burden of T2DM.9 Increasing number of diabetes cases were observed from 53,972 (2000), 61,583 (2005), 75,000 (2009), 1,45,600 (2012) to 1,70,000 (2013), and the number is predicted to rise to 2,17,000 (2025) and 3,26,400 (2030),8,12,16,17 with exposure to abundance of fast and high calorie food and sedentary lifestyles leading to major risk factors like overweight and obesity.8 It is predicted that there will be an increase in the number of diabetes cases by 124% in 2030 and 190% by 2050.1 T2DM is recognized as one of the leading causes of financial burden, disability and death in Oman.12,17 Identification of individuals at risk for T2DM can allow the risk factors, many of which are modifiable, to be addressed reducing the likelihood of developing T2DM.18
Significance
Major risk factors identified for DM can be used to guide screening strategies, preventive interventions and health policy development.19 The benefits of early detection and intervention on improved health outcomes and reduced morbidity associated with T2DM are shown in many studies.20–24 Studies also support the utilization of risk-assessment scoring systems in quantifying individual’s risk for developing T2DM.25–29
Many of the contributing risk factors are potentially modifiable.30,31 As the prevalence of DM among Omani adults rises despite measures to decrease morbidity, it is crucial for diabetes nurse educators (DNEs) to be able to identify high-risk populations. This prediction of new cases of T2DM in Oman, a largely preventable disorder, requires early identification and screening for mitigating early preventive and health promotion measures/actions for the local populations at high risk for developing T2DM. There is limited research examining the risk-assessment score of developing T2DM in Oman. This compels DNEs to empower the general public in identifying the risk factors and thus taking adequate preventive measures in combating DM. Thus, a self-administered risk-assessment scoring system for early screening of T2DM among Omani adults will be beneficial to identify high-risk adults.
Objective
The objective is to evaluate a risk-assessment scoring system for early screening among Omani adults for developing T2DM in a selected local community in Muscat.
Methodology
Design
An exploratory cross-sectional research design was used to evaluate the risk-assessment scoring system among adults in Muscat.
Setting, sample size and inclusion criteria
The target population consisted of adults undiagnosed with any endocrine illness, type 1 diabetes mellitus (T1DM) or T2DM, visiting the local primary health centre (PHC) in a local community and able to comprehend and communicate in Arabic or English language.32,33 Individuals with a diagnosis of endocrine illness, metabolic syndrome, pre-diabetes, T1DM, T2DM, apparent communicative, cognitive impairment or physical disability were excluded from the study. All potentially eligible individuals of the target population in a local PHC in Muscat were identified and assigned an identifier. Random tables were used to randomly select the individuals for the study in 2009.
The sample size was determined using 95% confidence interval,34 with a margin of error of 10% and 30% of the Omani population being overweight.13,35 The computed sample size was 103.
Measurements
Various risk factors of T2DM were reviewed from the literature like sex, age at diagnosis, ethnicity, family history of diabetes, diet and exercise, smoking and alcohol usage, hypertension, hyperlipidaemia, body mass index (BMI), weight, waist circumference (WC), gestational diabetes, macrosomia and polycystic ovarian syndrome.36–38 Various risk-assessment scoring systems were reviewed like American Diabetes Association,27 Rotterdam,29 Cambridge,20 Finnish,22 Danish,26 Indian,39 Thai,40 Omani,41 Kuwaiti,18 Australian T2DM risk-assessment tool42 and Trinidad Risk Assessment Questionnaire-5 (TRAQ-5).43 From a review of literature regarding risk factors of developing DM in Oman, the Finnish Diabetes Risk Score (FINDRISC) developed in 2001 and tested on Finnish population and in different countries22,44–48 was found to be useful for the Omani adults.
The FINDRISC had 8 risk factors correlating with the risk of developing T2DM and was used as a prognostic screening tool to detect a diabetes risk in a 10-year period based on age, family history, WC, BMI, physical activity, vegetable/fruit diet, past history of hypertension and blood glucose. It demonstrates the probability of developing T2DM within 10 years, and the risk score is categorized as <7: low (estimated 1 in 100 will develop DM), 7–11: slightly elevated (estimated 1 in 25 will develop DM), 12–14: moderate (estimated 1 in 6 will develop DM), 15–20: high (estimated 1 in 3 will develop DM) and >20: very high (estimated 1 in 2 will develop DM). Hence, the FINDRISC tool was found to be appropriate for the purpose of this study.
Anthropometric measurements of height and weight were measured by a reliable height scale and weighing scale, respectively. Fasting blood glucose (FBG) ≥126 mg/dL (7 mmol/L) was diagnosed using laboratory blood glucose test.26,32,49 BMI (weight in kilograms/square of height in metres (kg/m2)) was categorized as underweight (≤18.5 kg/m2), normal (BMI: 18–25 kg/m2), overweight (BMI: 25–30 kg/m2) and obese (BMI: ≥30 kg/m2). Hypertension was defined as a systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, or in case of use of anti-hypertensive medications27 was measured by a manual sphygmomanometer in standard conditions (measured 3 times after a 5-min rest between each measurement).50 WC ≥94 cm (39 inches) for males and ≥80 cm (35 inches) for females was considered as a risk factor for DM,51 and it was measured in a horizontal plane, midway between the inferior margin of the ribs and the superior border of the iliac crest using a reliable measuring inch tape.
Validity and reliability test
The FINDRISC tool was validated among three medical doctors (medicine, gastroenterologist and endocrinologist) in the local PHC and was found to be valid. The FINDRISC was administered to 30 selected Omani adults undiagnosed with T1DM or T2DM. The Cronbach’s alpha reliability of the tool was 0.84 and was found to be reliable for the study.
Ethical considerations and data collection
A total of 103 individuals were recruited in the study using simple random sampling. Three participants were excluded from the study because they did not meet eligibility criteria, three declined to participate in the study and four participants withdrew their participation after the informed consent citing personal reasons. Hence, 93 participants were recruited in the study.
Ethical approval was provided by the Ethics and Research Committee, College of Nursing and Sultan Qaboos University (SQU) Hospital, SQU in 2009. Written informed consent was obtained from each participant, before providing an informed document on the purposes of the study, the risks and benefits of participation, instructions and study questionnaire. Participants were assured of anonymity, voluntary participation and free will to withdraw from the study at any time without any consequences. All informed consents were stored and locked separately from data files in cabinets. Confidentiality was maintained by assigning code numbers to the data files.
Data analysis
Data were entered into Statistical Packages for Social Sciences (SPSS) version 18 for comparing, analysis and auditing for accuracy. Data were screened for missing values, logical inconsistencies and extreme values. There was no missing data. A probability of <0.05 was considered statistically significant for all tests. Descriptive summary and Pearson chi-square test were used to analyse the data.
Results
Demographic and clinical characteristics
Majority of the adults were below 45 years (90.3%) and men (87.1%; Table 1). Some of the adults were married (49.5%) and had a family history (parents, grandparents, aunts, uncles; 31.2%) of DM. A total of 55.9% of the adults had no daily physical activity (55.9%) and low intake of vegetables, fruits or berries (44.1%). Some of the adults had high BMI (26.9% are overweight and 18.3% are obese) and high WC (45.2%). A total of 35.5% of the adults had past hypertension and were on anti-hypertensive medications, and 26.9% had high blood glucose in the past. Those adults who reported past blood glucose (high) also had high FBG confirmed with the blood glucose test (26.9%).
Table 1.
Demographic and clinical and characteristics | Frequency | Percentage | |
---|---|---|---|
Age (years) | <45 | 84 | 90.3 |
45–54 | 8 | 8.6 | |
Above 55 | 1 | 1.1 | |
Family history of diabetes mellitus | No | 64 | 68.8 |
Grandparents, aunt, uncle and cousin | 18 | 19.4 | |
Parent, sibling and children | 11 | 11.8 | |
(BMI) | Normal: lower than 25 kg/m2 | 51 | 54.8 |
Overweight: 25–30 kg/m2 | 25 | 26.9 | |
Obese: higher than 30 kg/m2 | 17 | 18.3 | |
Waist circumference | Men: <94 cm and women: <80 cm | 51 | 54.8 |
Men: 94–102 cm and women: 80–88 cm | 37 | 39.8 | |
Men: >102 cm and women: >88 cm | 5 | 5.4 | |
Physical activity daily 30 min | Yes | 41 | 44.1 |
No | 52 | 55.9 | |
Vegetables, fruit or berry consumption | Every day | 52 | 55.9 |
Not every day | 41 | 44.1 | |
History of hypertensive and/or anti-hypertensives | No | 60 | 64.5 |
Yes | 33 | 35.5 | |
History of high blood glucose | No | 68 | 73.1 |
Yes | 25 | 26.9 | |
Fasting blood glucose | <7 mmol/L | 68 | 73.1 |
>7 mmol/L | 25 | 26.9 | |
Blood pressure | <140/90 mmHg | 60 | 64.5 |
>140/90 mmHg | 33 | 35.5 | |
Gender | Male | 81 | 87.1 |
Female | 12 | 12.9 | |
Marital status | Single | 47 | 50.5 |
Married | 46 | 49.5 |
BMI: body mass index.
Risk-assessment scoring system (FINDRISC) among Omani adults
A total of 28% of the Omani adults had slightly elevated diabetes risk score (DRS), while 17.2% had moderate DRS and 9.7% had very high DRS. This predicts that 26.9% of the Omani adults may develop T2DM within the consecutive 10 years, if no primary preventive measures are taken to curb it (Table 2).
Table 2.
Total risk score | Frequency | Percentage | |
---|---|---|---|
1 | Low risk <7 | 42 | 45.2 |
2 | Slightly elevated 7–11 | 26 | 28.0 |
3 | Moderate 12–14 | 16 | 17.2 |
4 | Very high 15–20 | 9 | 9.7 |
Total | 93 | 100.0 |
FINDRISC: Finnish Diabetes Risk Score.
Association between risk factors and FBG
FBG (≤7 and >7 mmol/L) was used to find association with the risk factors of T2DM. Family history of DM and marital status was significant with FBG (Table 3). Physical activity and dietary pattern were significant (p < 0.001) with FBG. BMI and WC were significantly associated with FBG (p < 0.001). Past history of hypertension/use of medications and high blood glucose were significant with FBG.
Table 3.
Risk factors and FBG | λ value | df | p | |
---|---|---|---|---|
Age (years) | <45 | 1.781 | 6 | .939ns |
45–54 | ||||
Above 55 | ||||
Family history | No | 26.545 | 6 | .000* |
Grandparents, aunt, uncle and cousin | ||||
Parent, sibling and children | ||||
BMI | Normal: Lower than 25 kg/m2 | 67.821 | 6 | .000* |
Overweight: 25–30 kg/m2 | ||||
Obese: Higher than 30 kg/m2 | ||||
Waist circumference | Men: <94 cm and women <80 cm | 69.995 | 6 | .000* |
Men: 94–102 cm and women: 80–88 cm | ||||
Men: >102 cm and women >88 cm | ||||
Physical activity daily 30 min | Yes | 55.754 | 3 | .000* |
No | ||||
Vegetables, fruit or berry consumption | Every day | 28.009 | 3 | .000* |
Not every day | ||||
History of hypertension | No | 50.245 | 3 | .000* |
Yes | ||||
History of high blood glucose | No | 8.588 | 3 | .035* |
Yes | ||||
Blood pressure | <140/90 mmHg | 50.245 | 3 | .000* |
>140/90 mmHg | ||||
Gender | Male | 1.267 | 3 | .737ns |
Female | ||||
Marital status | Single | 10.967 | 3 | .012* |
Married |
BMI: body mass index; ns: not significant; BMI: body mass index; FBG: fasting blood glucose; ns: not significant.
Pearson chi-square = λ value.
p < 0.001 = significant.
Discussion
In this study, among the non-modifiable risk factors, past history of hypertension or blood glucose were the most significant independent risk factors for predicting T2DM. However, BMI, WC, physical activity and dietary intake were the most significant risk factors. Increasing migration of Omanis to the cities were associated with major changes in lifestyles like escalation in car ownership, consumption of high fat caloric dense food, refined sugar and salt, less physical activity, overweight and the smoking habits.8,13 Behaviours and beliefs among Omani people with regard to health, nutrition, rituals, family structure, food habits (e.g. dates served with coffee), social and geographical elements mutually influence culture and vice versa.52 Individual differences in age, gender, education, experience, occupation and socio-economic factors also affect their beliefs and behaviours.52,53
Family history of DM, high BMI and WC, low physical activity and dietary intake of vegetables/fruits, history of hypertension and blood glucose were statistically significant with the FINDRISC among Omani adults.
Increase in WC and high BMI among Omani adults were related to poor lifestyle, physical activity (poor insulin sensitivity, hyperinsulinaemia, dyslipidaemia) and low consumption of vegetables and fruits among the Omani adults. One-fifth of the adult Omani population was overweight particularly visceral or abdominal, with increasing trend.2,54,55 Obesity was associated with 36.8% of diabetics.8,13,56 Hence, WC and BMI are better risk indicators of DM associated with increase in insulin resistance, hyperglycaemia and dyslipidaemia.57 WC (odds ratio (OR): 6.89, 95% confidence interval (CI): 1.95, 24.3), use of blood pressure medication (OR 2.66, 95% CI: 1.00, 7.05) and family history of a sibling with diabetes (OR: 2.66, 95% CI: 1.08, 6.54) were significant predictors of DM.18
There was a direct proportionate of FINDRISC with history of hypertension, anti-hypertensive medications or high blood glucose among the Omani adults. Hypertension is a major risk factor for atherosclerosis and diabetes.56 An increase in blood pressure is significantly associated with diabetes, particularly among urban-dwellers than rural areas.19,58,59 Also fasting plasma glucose and post challenge glucose concentrations are predictors of risk of DM.60 Using BMI, family history, history of high blood glucose or blood pressure was significantly a more predictive strategy for identifying risk for the development of DM due to interaction of race and diet.18,61
A quarter percentages of the Omani adults had very high or moderate elevated FINDRISC. The crude prevalence of total diabetes in Middle East was high (21.4%), with significant predictors like age, hypertension, obesity/WC/BMI and family history.18 This study consists of several known diabetes risk factors using a self-administered tool for identifying individuals with undiagnosed T2DM, which is 66% of all prevalent cases of T2DM in Omani adults.8 This assessment will help to increase awareness and motivate the public about the importance of modifiable anthropometric risk factors regarding T2DM.13,62
Conclusion
Among the modifiable risk factors that played a substantial role are BMI, WC, physical activity and dietary pattern. If modifiable risk factors are altered, the risk-assessment score can be considerably reduced. People with high risk of DM should be referred for early intervention and changes to a healthy lifestyle and primary prevention to prevent or delay the onset of T2DM. This article builds on the extant literature on risk factors for screening DM that can serve as a foundation for a concise and easy-to-administer self-report measure for identifying T2DM and prevention development of DM among Omani adults. This study provides a simple, feasible, non-invasive and convenient screening FINDRISC tool that identifies individuals at risk of having T2DM.
FINDRISC is a useful tool for identifying people with asymptomatic DM who might not seek early or regular evaluation, thus facilitating intervention early in the disease course. Early detection leads to a better quality of life, reduced morbidity, premature mortality and ultimately a reduction in associated health care and wider economic costs. FINDRISC may also be predictive of metabolic syndrome and cardiovascular disease as age, physical activity, dietary vegetables/fruits, WC, history of blood pressure or blood glucose are risk factors for both metabolic syndrome and cardiovascular disease. Adults with high-risk assessment, regardless of their blood glucose status, are suitable candidates for lifestyle modification, as these are risk factors for not only diabetes but also for metabolic syndrome and cardiovascular disease.
The health-care professionals and DNE can empower the patients in the high-risk group to be self-motivated with lifestyle modifications like increasing physical activity, maintaining ideal body weight and periodic health checks, including blood glucose and blood pressure. This should prompt high-risk adults with knowledge acquisition on prevention, early detection, treatment and disability limitation in prevention of DM leading to quality care.63,64 Risk assessment for DM has the potential to allow DNE to be more responsive to the needs of their patients and to develop new approaches to improve different aspects of lifestyle. A high dietary fibre and increase in vegetable consumption, low-moderate total calorie, reduced fat, low glycaemic index foods and low polyunsaturated fat will reduce the susceptibility to DM.65,66 At least 30 min of moderate physical activity with variable emphasis on high-intensity and resistance training exercise (e.g. brisk walking, swimming, cycling, dancing) on all or most days of the week is recommended. Regular walking for at least 30 min per day reduces diabetes risk by 35%−40%.67,68 Knowledge of risk of T2DM can enhance Omani adults’ awareness, leading to lifestyle modification.69 This has been proven to effectively prevent and delay the development of DM among young adults.
Implications for DNEs
Prevention of T2DM among young adults at increased risk includes a simple three-step plan for identification of those who may be at higher risk, measurement of risk and the intervention to prevent the development of T2DM.66,70,71 DNE should use the risk-assessment system, identify adults in high-risk group and empower them with lifestyle modification to delay the early onset of DM. This will result in decrease in incidence and prevalence of DM, and a decrease in burden on the health-care system.64,72 Innovative methods should be integrated with focus on primary prevention of diabetes, early screening and detection of pre-diabetes population. DNE should be educated towards empowering self-management individualized tailored programme to deliver important information (diet, exercise, foot care, medications, blood glucose, stress management, prevention of risk factors and early detection of complications).
Psychosocial factors also provide an important foundation to establish goals and maintain the motivation to adhere the strategies that prevent DM.65,73 Knowledge of determinants influencing early glycaemic control can be used by DNE to provide targeted interventions to those at greatest risk of short- or long-term complications. These have direct impact on the economic state of patients and families. These results can be utilized by DNE to emphasize management, motivation and reinforcement in adhering to self-care activities and efficacy in self-management of diabetes. The role of the DNE in ongoing assessment, continuous monitoring, close supervision, reinforcement of education and prevention of T2DM is important.
Limitations
This study is limited by the cross-sectional design and is not causal or effect study or measure of temporal changes. Some factors that can influence blood glucose levels (e.g. co-morbid conditions, genetically inherited haemoglobinopathies) have not been studied. Validation of the risk assessment with a large sample size in different populations would have enhanced the generalizability of the results.
Acknowledgments
The authors gratefully acknowledge the content experts and language editors for valuable suggestions during the study.
Footnotes
Declaration of conflicting interests: There are no organizations or communities with conflict of interest or coveting interests related to the study. The co-authors declare that they have no competing interests.
Funding: This study was funded by College of Nursing, Sultan Qaboos University.
References
- 1. International Diabetes Federation. Diabetes Atlas. 3rd ed., 2006, https://www.idf.org/sites/default/files/Diabetes%20Atlas%203rd%20edition.pdf
- 2. Al-Moosa S, Allin S, Jemiai N, et al. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr 2006; 4: 5–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Hu G, Lindström J, Valle TT, et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004; 164: 892–896. [DOI] [PubMed] [Google Scholar]
- 4. Hu G, Qiao Q, Silventoinen K, et al. Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and women. Diabetologia 2003; 46: 322–329. [DOI] [PubMed] [Google Scholar]
- 5. World Health Organization (WHO). Diet, nutrition and the prevention of chronic diseases. Report of a Joint FAO/WHO Consultation. WHO Technical Report Series 916. Report no. WHO/NMH/MNC/03.1, 2003. Geneva: Department of Noncommunicable Disease Management, WHO. [Google Scholar]
- 6. Montonen J, Knekt P, Järvinen R, et al. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 2003; 77: 622–629. [DOI] [PubMed] [Google Scholar]
- 7. International Diabetes Federation. Diabetes Atlas. 5th ed., 2009, http://www.idf.org/diabetesatlas/5e/the-globalburden
- 8. Al-Lawati JA, Al Riyami AM, Mohammed AJ, et al. Increasing prevalence of diabetes mellitus in Oman. Diabet Med 2002; 9(11): 954–957. [DOI] [PubMed] [Google Scholar]
- 9. Al-Lawati JA, Mabry R, Mohammed AJ. Addressing the threat of chronic diseases in Oman. Prev Chronic Dis 2008; 5(3): A99 http://www.cdc.gov/pcd/issues/2008/jul/07_0086.htm [PMC free article] [PubMed] [Google Scholar]
- 10. Bhattacharjee M. Diabetes cases in Sultanate to rise 124% by 2030: IDF. Muscat Daily, http://www.muscatdaily.com (2003. accessed 20 August 2013).
- 11. World Health Organization (WHO). Global strategy on diet, physical activity and health. Geneva: WHO, 2007. [Google Scholar]
- 12. Editorial. Type 2 diabetes – time to change our approach. Lancet 2010; 375(9733): 2193. [DOI] [PubMed] [Google Scholar]
- 13. Al-Lawati JA, Jousilahti PJ. Prevalence and 10-year secular trend of obesity in Oman. Saudi Med J 25(3) 2004; 346–351. [PubMed] [Google Scholar]
- 14. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, et al. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003; 26(6): 1781–1785. [DOI] [PubMed] [Google Scholar]
- 15. Shetty P, Schmidhuber J. Nutrition, lifestyle, obesity and chronic disease. United Nations Report. Expert paper no 2011/3, http://www.un.org/esa/population/publications/expertpapers/2011-3-shetty.pdf
- 16. Ministry of Health. Oman program for control of non-communicable diseases. Muscat, Oman: International Printing Press, 1996; 5th Five Year Health Plan 1995–2000, pp. 12–15. [Google Scholar]
- 17. Ministry of Health. Annual health report. Communicable Diseases Control in the Sultanate of Oman. Muscat, Oman: Ministry of Health, 2005, pp. 9–55. [Google Scholar]
- 18. National Institute for Health and Care Excellence. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. NICE public health guidance 38 2012, London. [Google Scholar]
- 19. Mainous AG, III, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann Fam Med 2007; 5: 425–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Griffin SJ, Little PS, Hales CN, et al. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16(3): 164–171. [DOI] [PubMed] [Google Scholar]
- 21. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000; 23(10): 1563–1580. [DOI] [PubMed] [Google Scholar]
- 22. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725–731. [DOI] [PubMed] [Google Scholar]
- 23. Glumer C, Carstensen B, Sandbaek A, et al. Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004; 27(3): 727–733. [DOI] [PubMed] [Google Scholar]
- 24. Spijkerman A, Yuyun M, Griffin SJ, et al. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care 2007; 27: 116–122. [DOI] [PubMed] [Google Scholar]
- 25. Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97(18): 1837–1847. [DOI] [PubMed] [Google Scholar]
- 26. Glumer C, Jorgensen T, Borch-Johnsen K. Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8). Diabet Med 2004; 21: 874–880. [DOI] [PubMed] [Google Scholar]
- 27. Herman WH, Smith PJ, Thompson TJ, et al. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18(3): 382–387. [DOI] [PubMed] [Google Scholar]
- 28. Wilson PWF, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007; 167: 1068–1074. [DOI] [PubMed] [Google Scholar]
- 29. Baan CA, Ruige JB, Stolk RP, et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 1999; 22(2): 213–219. [DOI] [PubMed] [Google Scholar]
- 30. Franciosi M, De Berardis G, Rossi MC, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 2005; 28(5): 1187–1194. [DOI] [PubMed] [Google Scholar]
- 31. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28(8): 2013–2018. [DOI] [PubMed] [Google Scholar]
- 32. American Diabetes Association. Standards of Medical Care in Diabetes – 2013. Diabetes Care 2013; 36(1): S11–S65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. American Diabetes Association. Executive summary: standards of medical care in diabetes – 2011. Diabetes Care 2011; 34(Suppl. 1): S4–S10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behav Res Methods 2007; 39: 175–191. [DOI] [PubMed] [Google Scholar]
- 35. Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients – a randomized controlled trial. Patient Educ Couns 2009; 77(1): 72–80. [DOI] [PubMed] [Google Scholar]
- 36. Van Der Ven NC, Weinger K, Yi J, et al. The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care 2003; 26(3): 713–718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Janssen I, Katzmarzyk PT, Ross RS. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004; 79(3): 379–384. [DOI] [PubMed] [Google Scholar]
- 38. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329: 168–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Mohan V, Deepa R, Deepa M, et al. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc of Physicians India 2005; 53: 759–763. [PubMed] [Google Scholar]
- 40. Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai Population. Diabetes Care 2006; 29: 1872–1877. [DOI] [PubMed] [Google Scholar]
- 41. Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 2007; 77(3): 438–444. [DOI] [PubMed] [Google Scholar]
- 42. Chen L, Magliano DJ, Balkau B, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010; 192(5): 274. [DOI] [PubMed] [Google Scholar]
- 43. Latchan Z, Seereeram R, Kamalodeen A, et al. TRAQ-D (Trinidad Risk Assessment Questionnaire for Type 2 Diabetes Mellitus): a cheap, reliable, non-invasive screening tool for diabetes. Br J Diabetes Vasc Dis 2010; 10: 187–192. [Google Scholar]
- 44. Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 2007; 66(2): 101–112. [DOI] [PubMed] [Google Scholar]
- 45. Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, et al. ; DE-PLAN project. The European perspective of type 2 diabetes prevention: diabetes in Europe – prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diab 2008; 116(3): 167–172. [DOI] [PubMed] [Google Scholar]
- 46. Schwarz PEH, Li J, Reimann M, et al. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 920–926. [DOI] [PubMed] [Google Scholar]
- 47. Bergmann A, Li J, Wang L, et al. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 2007; 39(9): 677–682. [DOI] [PubMed] [Google Scholar]
- 48. Allsema M, Feskens EJ, Bakker SJ, et al. Finnish questionnaire reasonably good predictor of the incidence of diabetes in The Netherlands. Ned Tijdschr Geneeskd 2008; 152(44): 2418–2424. [PubMed] [Google Scholar]
- 49. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. Report no. WHO/NCD/NCS/99.2, 1999. Geneva: WHO. [Google Scholar]
- 50. Smith Liz. New AHA recommendations for blood pressure measurement: American Heart Association Practice Guidelines. Am Fam Physician 2005; 72(7): 1391–1398. [Google Scholar]
- 51. Alberti G, Zimmet P, Shaw J. Metabolic syndrome – a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Met 2006; 23: 469–480. [DOI] [PubMed] [Google Scholar]
- 52. Al-Shookri A, Khor GL, Chan YM, et al. Review: type 2 diabetes in the sultanate of Oman. Malays J Nutr 2005; 17(1): 129–141. [PubMed] [Google Scholar]
- 53. Hofstede G. Cultures and organizations: software of the mind. 1st ed. Berkshire: McGraw-Hill, 1991. [Google Scholar]
- 54. Selvin E, Wattanakit K, Steffes MW, et al. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2006; 29(4): 877–882. [DOI] [PubMed] [Google Scholar]
- 55. Toner JM, Close CF, Ramsay LE. Factors related to treatment resistance in hypertension. Q J Med 1990; 77(283): 1195–1204. [DOI] [PubMed] [Google Scholar]
- 56. Al-Riyami A, Afifi M. Distribution and correlates of total impaired fasting glucose in Oman. East Mediterr Health J 2003; 9: 377–389. [PubMed] [Google Scholar]
- 57. Ostlund RE, Jr, Staten M, Kohrt WM, et al. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990; 322(4): 229–234. [DOI] [PubMed] [Google Scholar]
- 58. Al-Mahroos F, Al-Roomi K, McKeigue P. Relation of high blood pressure to glucose intolerance, plasma lipids and educational status in an Arabian Gulf population. Int J Epidemiol 2000; 29: 71–76. [DOI] [PubMed] [Google Scholar]
- 59. Njolstad I, Arnesen E, Lund-Larsen PG. Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study. Am J Epidemiol 1998; 147: 49–58. [DOI] [PubMed] [Google Scholar]
- 60. Li J, Bergmann A, Reimann M, et al. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome. Horm Metab Res 2009; 41(2): 98–103. [DOI] [PubMed] [Google Scholar]
- 61. Mainous AG, III, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann Fam Med 2007; 5(5): 425–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Abdul-Rahim HF, Holmboe-Ottesen G, Stene LC, et al. Obesity in a rural and an urban Palestinian West Bank population. Int J Obes Relat Metab Disord 2003; 27(1): 140–146. [DOI] [PubMed] [Google Scholar]
- 63. International Diabetes Federation. Global guideline for type 2 diabetes, 2010, http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf
- 64. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486–2497. [DOI] [PubMed] [Google Scholar]
- 65. Alyaarubi S. Diabetes care in Oman: obstacles and solutions. Sultan Qaboos Univ Med J 2011; 11(3): 343–348. [PMC free article] [PubMed] [Google Scholar]
- 66. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15(7): 539–553. [DOI] [PubMed] [Google Scholar]
- 67. Chien KL, Hsu HC, Su TC, et al. Fasting and post challenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. Am Heart J 2008; 156(5): 996–1002. [DOI] [PubMed] [Google Scholar]
- 68. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366(9491): 1059–1062. [DOI] [PubMed] [Google Scholar]
- 69. Haffner S. Diabetes and the metabolic syndrome – when is it best to intervene to prevent? Atheroscler Suppl 2006; 7: 3–10. [DOI] [PubMed] [Google Scholar]
- 70. Spijkerman AM, Henry RM, Dekker JM, et al. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn screening study. J Intern Med 2004; 256: 429–436. [DOI] [PubMed] [Google Scholar]
- 71. World Health Organization (WHO). Screening for type 2 diabetes: report of a World Health Organization and International Diabetes Federation meeting. Report no. WHO/NMH/MNC/03.1, 2003. Geneva: Department of Noncommunicable Disease Management, WHO. [Google Scholar]
- 72. World Health Organization (WHO). The world health report 2002: reducing risks, promoting healthy life. World Health Report, 2002. Geneva: WHO. [Google Scholar]
- 73. Delamater AM. Improving patient adherence. Clinical Diabetes 2006; 24(2): 71–76. [Google Scholar]